Combination of angiopoietin-2 antagonist and of VEGF-A, KDR and/or Flt1 antagonist for treating cancer

Details for Australian Patent Application No. 2011201326 (hide)

Owner MedImmune Limited

Inventors Brown, Jeffrey Lester; Emery, Stephen Charles; Blakey, David Charles

Agent Davies Collison Cave

Pub. Number AU-B-2011201326

Parent 2006324477

Filing date 23 March 2011

Wipo publication date 14 April 2011

Acceptance publication date 12 January 2012

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 31/00 (2006.01)

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

7 April 2011 Complete Application Filed

14 April 2011 Application Open to Public Inspection

  Published as AU-B-2011201326

12 January 2012 Application Accepted

  Published as AU-B-2011201326

10 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011201327-Electric drive vehicle

2011201325-Induction of exon skipping in eukaryotic cells